Nukkleus Inc. (NUKK) files 8-K noting Nov. 25, 2025 press release

Rhea-AI Filing Summary

Nukkleus Inc. filed a current report to note that it issued a press release on November 25, 2025, which is attached as Exhibit 99.1. The report classifies this under an "Other Events" section, meaning the company is formally making investors aware of information contained in that press release.

The filing also lists Nukkleus’ securities that trade on The Nasdaq Global Market, including its common stock under the symbol NUKK and warrants under NUKKW, each exercisable for one share of common stock at $92.00 per share. The company states that the press release and related exhibit are being furnished rather than filed, which affects how they are treated under securities law liability provisions.

false 0001787518 0001787518 2025-11-25 2025-11-25 0001787518 NUKK:CommonStock0.0001ParValuePerShareMember 2025-11-25 2025-11-25 0001787518 NUKK:WarrantsEachWarrantExercisableForOneShareOfCommonStockFor92.00PerShareMember 2025-11-25 2025-11-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 25, 2025

NUKKLEUS INC.
(Exact name of registrant as specified in its charter)

Delaware		001-39341		38-3912845
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(IRS Employer Identification Number)

575 Fifth Avenue, 14th Floor

New York, New York 10017

(Address of principal executive offices)

212-791-4663

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		NUKK		The Nasdaq Global Market
Warrants, each warrant exercisable for one Share of Common Stock for $92.00 per share		NUKKW		The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 8.01 Other Events.

On November 25, 2025, Nukkleus Inc. issued a press release, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information furnished under this Item 8.01, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

	Exhibit 99.1	Press Release dated November 25, 2025
	Exhibit 104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NUKKLEUS INC.
Date: November 25, 2025	By:	/s/ Menachem Shalom
	Name:	Menachem Shalom
	Title:	Chief Executive Officer

2

FAQ

What did Nukkleus Inc. (NUKK) disclose in this 8-K filing?

Nukkleus Inc. disclosed that it issued a press release dated November 25, 2025, which is attached to the report as Exhibit 99.1 and identified under the "Other Events" section.

How are Nukkleus Inc. shares and warrants listed in this document?

The filing states that Nukkleus’ common stock trades on The Nasdaq Global Market under the symbol NUKK, and its warrants, each exercisable for one share of common stock at $92.00 per share, trade under the symbol NUKKW.

Is the Nukkleus (NUKK) press release in this 8-K considered filed with the SEC?

The company specifies that the information under Item 8.01, including Exhibit 99.1, is being furnished and not deemed filed for purposes of Section 18 of the Exchange Act.

Who signed this Nukkleus Inc. 8-K report?

The report was signed on behalf of Nukkleus Inc. by Menachem Shalom, who is identified as the company’s Chief Executive Officer.

What exhibits are included with this Nukkleus (NUKK) 8-K?

The filing lists two exhibits: Exhibit 99.1, a press release dated November 25, 2025, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.